News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
719,828 Results
Type
Article (42621)
Company Profile (295)
Press Release (676912)
Multimedia
Podcasts (81)
Webinars (12)
Section
Business (210537)
Career Advice (2095)
Deals (36645)
Drug Delivery (107)
Drug Development (83082)
Employer Resources (175)
FDA (16588)
Job Trends (15421)
News (356207)
Policy (33941)
Tag
Academia (2601)
Accelerated approval (5)
Adcomms (21)
Allergies (92)
Alliances (51461)
ALS (97)
Alzheimer's disease (1402)
Antibody-drug conjugate (ADC) (140)
Approvals (16584)
Artificial intelligence (277)
Autoimmune disease (24)
Automation (16)
Bankruptcy (372)
Best Places to Work (11773)
BIOSECURE Act (20)
Biosimilars (112)
Biotechnology (189)
Bladder cancer (78)
Brain cancer (29)
Breast cancer (293)
Cancer (2349)
Cardiovascular disease (188)
Career advice (1756)
Career pathing (31)
CAR-T (155)
Cell therapy (440)
Cervical cancer (20)
Clinical research (67633)
Collaboration (877)
Company closure (2)
Compensation (564)
Complete response letters (25)
COVID-19 (2664)
CRISPR (48)
C-suite (257)
Cystic fibrosis (105)
Data (2313)
Decentralized trials (2)
Denatured (29)
Depression (47)
Diabetes (279)
Diagnostics (6465)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (124)
Drug pricing (115)
Drug shortages (28)
Duchenne muscular dystrophy (97)
Earnings (88691)
Editorial (41)
Employer branding (21)
Employer resources (149)
Events (115551)
Executive appointments (754)
FDA (17973)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (776)
Gene editing (117)
Generative AI (21)
Gene therapy (326)
GLP-1 (758)
Government (4551)
Grass and pollen (5)
Guidances (150)
Healthcare (19013)
Huntington's disease (25)
IgA nephropathy (28)
Immunology and inflammation (131)
Indications (30)
Infectious disease (2809)
Inflammatory bowel disease (147)
Inflation Reduction Act (8)
Influenza (52)
Intellectual property (99)
Interviews (323)
IPO (16804)
IRA (47)
Job creations (4061)
Job search strategy (1493)
Kidney cancer (10)
Labor market (43)
Layoffs (499)
Leadership (20)
Legal (8380)
Liver cancer (77)
Lung cancer (326)
Lymphoma (158)
Machine learning (9)
Management (59)
Manufacturing (338)
MASH (75)
Medical device (13476)
Medtech (13481)
Mergers & acquisitions (20404)
Metabolic disorders (727)
Multiple sclerosis (82)
NASH (18)
Neurodegenerative disease (97)
Neuropsychiatric disorders (29)
Neuroscience (1972)
NextGen: Class of 2025 (6648)
Non-profit (4539)
Now hiring (40)
Obesity (387)
Opinion (232)
Ovarian cancer (81)
Pain (103)
Pancreatic cancer (89)
Parkinson's disease (152)
Partnered (21)
Patents (247)
Patient recruitment (116)
Peanut (49)
People (59347)
Pharmaceutical (91)
Pharmacy benefit managers (20)
Phase I (20977)
Phase II (29768)
Phase III (22297)
Pipeline (1359)
Policy (159)
Postmarket research (2654)
Preclinical (8944)
Press Release (68)
Prostate cancer (108)
Psychedelics (31)
Radiopharmaceuticals (252)
Rare diseases (403)
Real estate (6265)
Recruiting (67)
Regulatory (23199)
Reports (47)
Research institute (2371)
Resumes & cover letters (358)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (78)
Series A (134)
Series B (88)
Service/supplier (12)
Sickle cell disease (56)
Special edition (17)
Spinal muscular atrophy (150)
Sponsored (30)
Startups (3733)
State (2)
Stomach cancer (14)
Supply chain (69)
Tariffs (52)
The Weekly (50)
Vaccines (719)
Venture capitalists (42)
Weight loss (256)
Women's health (36)
Worklife (16)
Date
Last 7 days (941)
Last 30 days (3030)
Last 365 days (32864)
2025 (11869)
2024 (35784)
2023 (40643)
2022 (51808)
2021 (56341)
2020 (54811)
2019 (47431)
2018 (35797)
2017 (33165)
2016 (32687)
2015 (38627)
2014 (32530)
2013 (27645)
2012 (29744)
2011 (30499)
2010 (28506)
Location
Africa (782)
Alabama (54)
Alaska (7)
Arizona (240)
Arkansas (14)
Asia (40775)
Australia (6537)
California (6405)
Canada (2074)
China (549)
Colorado (274)
Connecticut (280)
Delaware (159)
Europe (87147)
Florida (950)
Georgia (212)
Idaho (57)
Illinois (559)
India (26)
Indiana (327)
Iowa (11)
Japan (175)
Kansas (106)
Kentucky (24)
Louisiana (11)
Maine (62)
Maryland (928)
Massachusetts (4799)
Michigan (225)
Minnesota (403)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (67)
New Hampshire (63)
New Jersey (1800)
New Mexico (29)
New York (1809)
North Carolina (1008)
North Dakota (8)
Northern California (2812)
Ohio (208)
Oklahoma (14)
Oregon (39)
Pennsylvania (1428)
Puerto Rico (13)
Rhode Island (33)
South America (1165)
South Carolina (25)
South Dakota (1)
Southern California (2411)
Tennessee (105)
Texas (954)
United States (24114)
Utah (190)
Virginia (160)
Washington D.C. (64)
Washington State (570)
West Virginia (3)
Wisconsin (59)
719,828 Results for "catalyst pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Catalyst Pharmaceuticals to Participate in the BofA Securities Health Care Conference 2025
April 30, 2025
·
2 min read
Press Releases
Catalyst Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Provides Business Update
May 8, 2025
·
13 min read
Press Releases
Catalyst Pharmaceuticals to Report First Quarter 2025 Financial Results on May 7, 2025
April 23, 2025
·
2 min read
Press Releases
Catalyst Pharmaceuticals Announces Health Canada’s Acceptance of AGAMREE® New Drug Submission with Priority Review for Sub-Licensee Kye Pharmaceuticals
April 9, 2025
·
5 min read
Press Releases
Jaguar Health Provides Overview of 2025 Crofelemer-Related Catalysts
May 7, 2025
·
7 min read
Catalyst Pharmaceuticals to Participate at the Jefferies Global Healthcare Conference 2024
Catalyst Pharmaceuticals, Inc. (“Catalyst” or “Company”) (Nasdaq: CPRX) today announced that Richard J. Daly, President and CEO of Catalyst, along with other members of Catalyst’s management team, will participate at the upcoming Jefferies Global Healthcare Conference 2024 on Wednesday, June 5, 2024, in New York.
May 28, 2024
·
3 min read
Press Releases
Catalyst Pharmaceuticals to Participate in the Barclays 27th Annual Global Healthcare Conference
March 4, 2025
·
2 min read
Catalyst Pharmaceuticals to Participate at the BofA Securities Health Care Conference 2024
Catalyst Pharmaceuticals, Inc. today announced that Richard J. Daly, President and CEO of Catalyst, along with other members of Catalyst’s management team, will participate at the upcoming BofA Securities Health Care Conference.
May 1, 2024
·
3 min read
Catalyst Pharmaceuticals Receives U.S. FDA Approval For Increased Maximum Daily Dose For FIRDAPSE®
Catalyst Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (“FDA”) has approved its supplemental New Drug Application (“sNDA”) increasing the indicated maximum daily dose of FIRDAPSE.
May 30, 2024
·
4 min read
Business
Catalyst Pharmaceuticals Reports Solid First Quarter 2024 Financial Results and Provides Business Update
Catalyst Pharmaceuticals, Inc. (“Catalyst” or “Company”) (Nasdaq: CPRX) today reported financial results for the first quarter of 2024 and provided a business update.
May 8, 2024
·
12 min read
1 of 71,983
Next
